Anti-inflammatory, anticholesterol drugs vs. cancer
By Nathan Seppa
From Anaheim, Calif., at a meeting of the American Association for Cancer Research
Cholesterol-lowering drugs, especially when combined with anti-inflammatory medication, may inhibit some cancers, two studies suggest.
Tapping into a database that tracks the health of more than 51,000 middle-aged and elderly men, researchers identified 2,074 who developed prostate cancer between 1990 and 2000. In 283 of the men, the cancer was lethal or potentially so, having spread to lymph nodes or other organs.